Other Species / Isoforms
  eIF3-epsilon (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S46-p
PAAAPASsSDPAAAA
Upstream
Downstream
2 1
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • CDK11B (human)
  • CDK19 (human)
Putative in vivo kinases:
  • CDK11B (human)
  • CDK19 (human)
eIF3-epsilon (human) PAAAPASsSDPAAAA S46-p
eIF3-epsilon (mouse) AASPAPVSSDPAVAA S52
eIF3-epsilon (rat) under review -
S105-p
ILASIVDsYERRNEG
0 1
eIF3-epsilon (human) ILASIVDsYERRNEG S105-p
eIF3-epsilon (mouse) ILASIVDSYERRNEG S109
eIF3-epsilon (rat) under review -
T119-p
GAARVIGtLLGTVDK
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, induced
  • translation, altered
Kinase, in vitro:
  • CDK19 (human)
Putative in vivo kinases:
  • CDK19 (human)
eIF3-epsilon (human) GAARVIGtLLGTVDK T119-p
eIF3-epsilon (mouse) GAARVIGTLLGTVDK T123
eIF3-epsilon (rat) under review -
S142-p
FSVPHNEsEDEVAVD
0 1
eIF3-epsilon (human) FSVPHNEsEDEVAVD S142-p
eIF3-epsilon (mouse) FSVPHNESEDEVAVD S146
eIF3-epsilon (rat) under review -
K154-ub
AVDMEFAkNMYELHk
0 1
eIF3-epsilon (human) AVDMEFAkNMYELHk K154-ub
eIF3-epsilon (mouse) AVDMEFAKNMYELHK K158
eIF3-epsilon (rat) under review -
K161-ub
kNMYELHkKVSPNEL
0 1
eIF3-epsilon (human) kNMYELHkKVSPNEL K161-ub
eIF3-epsilon (mouse) KNMYELHKKVSPNEL K165
eIF3-epsilon (rat) under review -
K214-ub
QNGRMSIkAYVSTLM
1 1
eIF3-epsilon (human) QNGRMSIkAYVSTLM K214-ub
eIF3-epsilon (mouse) QHGRMSIkAYVSTLM K218-ub
eIF3-epsilon (rat) under review -
T233-p
RTMGVMFtPLTVkYA
0 1
eIF3-epsilon (human) RTMGVMFtPLTVkYA T233-p
eIF3-epsilon (mouse) RTMGVMFTPLTVkYA T237
eIF3-epsilon (rat) under review -
K238-ac
MFtPLTVkYAyYDtE
0 3
eIF3-epsilon (human) MFtPLTVkYAyYDtE K238-ac
eIF3-epsilon (mouse) MFTPLTVkYAyYDTE K242-ac
eIF3-epsilon (rat) under review -
K238-ub
MFtPLTVkYAyYDtE
1 13
eIF3-epsilon (human) MFtPLTVkYAyYDtE K238-ub
eIF3-epsilon (mouse) MFTPLTVkYAyYDTE K242-ub
eIF3-epsilon (rat) under review -
Y241-p
PLTVkYAyYDtERIG
0 7
eIF3-epsilon (human) PLTVkYAyYDtERIG Y241-p
eIF3-epsilon (mouse) PLTVkYAyYDTERIG Y245-p
eIF3-epsilon (rat) under review -
T244-p
VkYAyYDtERIGVDL
0 1
eIF3-epsilon (human) VkYAyYDtERIGVDL T244-p
eIF3-epsilon (mouse) VkYAyYDTERIGVDL T248
eIF3-epsilon (rat) under review -
K254
IGVDLIMKtCFsPNr
1 0
eIF3-epsilon (human) IGVDLIMKtCFsPNr K254
eIF3-epsilon (mouse) IGVDLIMktCFsPNR K258-ub
eIF3-epsilon (rat) under review -
T255-p
GVDLIMKtCFsPNrV
Upstream
0 7
Treatment
  • BI2536
eIF3-epsilon (human) GVDLIMKtCFsPNrV T255-p
eIF3-epsilon (mouse) GVDLIMktCFsPNRV T259-p
eIF3-epsilon (rat) under review -
S258-p
LIMKtCFsPNrVIGL
Upstream
0 44
Treatment
  • nocodazole
eIF3-epsilon (human) LIMKtCFsPNrVIGL S258-p
eIF3-epsilon (mouse) LIMktCFsPNRVIGL S262-p
eIF3-epsilon (rat) under review -
R261-m1
KtCFsPNrVIGLssD
0 1
eIF3-epsilon (human) KtCFsPNrVIGLssD R261-m1
eIF3-epsilon (mouse) ktCFsPNRVIGLSSD R265
eIF3-epsilon (rat) under review -
S266-p
PNrVIGLssDLQQVG
0 3
eIF3-epsilon (human) PNrVIGLssDLQQVG S266-p
eIF3-epsilon (mouse) PNRVIGLSSDLQQVG S270
eIF3-epsilon (rat) under review -
S267-p
NrVIGLssDLQQVGG
0 2
eIF3-epsilon (human) NrVIGLssDLQQVGG S267-p
eIF3-epsilon (mouse) NRVIGLSSDLQQVGG S271
eIF3-epsilon (rat) under review -
K297-ub
AEDVLSGkVSADNTV
1 1
eIF3-epsilon (human) AEDVLSGkVSADNTV K297-ub
eIF3-epsilon (mouse) AEDVLSGkVSADNTV K301-ub
eIF3-epsilon (rat) under review -
K317
SLVNQVPKIVPDDFE
1 0
eIF3-epsilon (human) SLVNQVPKIVPDDFE K317
eIF3-epsilon (mouse) SLVNQVPkIVPDDFE K321-ub
eIF3-epsilon (rat) under review -
K353
SQIALNEKLVNL___
1 0
eIF3-epsilon (human) SQIALNEKLVNL___ K353
eIF3-epsilon (mouse) SQIALNEkLVNL___ K357-ub
eIF3-epsilon (rat) under review -